Guardant Health, Inc.
Clinical trials sponsored by Guardant Health, Inc., explained in plain language.
Precision oncology company developing liquid biopsy tests for cancer detection and monitoring.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test aims to catch lung cancer before it spreads Results expected Dec 2026 (estimated)
-
Blood test aims to catch Cancer's return earlier
Diagnosis Recruiting nowThe ORACLE study watches people who have finished treatment for early-stage solid tumors, such as lung, breast, colon, and pancreatic cancers. Researchers want to see if a blood test called Guardant Reveal can find tiny traces of tumor DNA that might signal the cancer is coming b…
Sponsor: Guardant Health, Inc. • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Blood test aims to track cancer treatment response in real time
Diagnosis Recruiting nowResearchers are studying whether a blood test called Guardant360 can measure how well cancer treatment is working in people with advanced lung, colorectal, or breast cancer. The test looks for tumor DNA that cancer cells release into the bloodstream. Participants give blood sampl…
Sponsor: Guardant Health, Inc. • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Blood test could spot colon cancer in second round of screening
Diagnosis Recruiting nowThis study looks at how well the Shield blood test finds colorectal cancer and advanced growths in people aged 45 to 81 who are at average risk. About 3,375 participants will take the test and then have a colonoscopy to compare results. The goal is to see if the blood test works …
Sponsor: Guardant Health, Inc. • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC